Hopefully they are done issuing warrants! I know in the Fall they were just "doing what they had to do" to keep the doors open, but it nets out to about 28% per share dilution as a result of the financing. TTNP went from being 99.5 million shares fully diluted, to about 137 million shares.
On the positive side, to get the common stock under the warrants they have to pay the exercise price. There are 5.4 million in 2012 Series A Warrants with an exercise price of $0.89...which would result in proceeds to TTNP of $4,806,000. There are 15.75 million in 2014 Class A Warrants with an exercise price of $0.60...which would result in proceeds of $9.45 million.
So along with the $15 million milestone payment upon Probuphine approval, TTNP could receive up to another $15 million if the warrants are all exercised.